Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat

British Journal of Nutrition

Volumn 92, Issue 1, 2004, Pages 119-127

  Puel, C ^a   Quintin, A ^a   Agalias, A ^b   Mathey, J ^a   Obled, C ^a   Mazur, A ^a   Davicco, M J ^a   Lebecque, P ^a   Skaltsounis, A L ^b   Coxam, Véronica ^a  

^a CEMAGREF   (France)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARACHIS OIL; BIOLOGICAL MARKER; CALCIUM; CHOLINE; DEOXYPYRIDINOLINE; MAGNESIUM SILICATE; METHIONINE; OLEUROPEIN; OLIVE OIL; OROSOMUCOID; OSTEOCALCIN; PHENOL DERIVATIVE; PHOSPHORUS; RAPESEED OIL; TRACE ELEMENT; ANTIINFECTIVE AGENT; EDIBLE OIL; PYRAN DERIVATIVE; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; AUTOPSY; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FEMUR; FOOD INTAKE; INFLAMMATORY DISEASE; METAPHYSIS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; PROTEIN BLOOD LEVEL; RAT; URINARY EXCRETION; UTERUS HORN; UTERUS WEIGHT; ANIMAL; BLOOD; BONE DEVELOPMENT; INFLAMMATION; METABOLIC BONE DISEASE; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; UTERUS; WISTAR RAT;

ARACHIS HYPOGAEA; SINAPIS ARVENSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; DIETARY FATS, UNSATURATED; FEMALE; INFLAMMATION; ORGAN SIZE; OROSOMUCOID; OSTEOGENESIS; OVARIECTOMY; PLANT OILS; PYRANS; RATS; RATS, WISTAR; UTERUS;

EID: 3142621283     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20041181     Document Type: Article

References (44)

1. Armour KE, Van'T Hof RJ, Grabowski PS, Reid DM & Ralston SH (1999) Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14, 2137-3142.
2. Benzie FF & Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239, 70-76.
3. Bors W, Heller W, Michel C & Saran M (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 186, 343-355.
4. Breuillé D, Arnal M, Rambourdin F, Bayle G, Levieux D & Obled C (1998) Sustained modifications of protein metabolism in various tissues in a rat model of long-lasting sepsis. Clin Sci (Lond) 94, 413-423.
5. Browner WS, Pressman AR, Nevitt MC & Cummings SR (1996) Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156, 1521-1525.
6. Chaudiere J (1994) Some chemical and biochemical constraints of oxidative stress in living cells. In Free Radical Damage and its Control, pp. 25-66 [CA Rice-Evans and RH Burdon, editors]. New York: Elsevier-Science.
7. Cohen-Solal ME, Graulet AM & Denne MA (1993) Peripheral monocyte culture supernatants of menopausal women induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77, 1648-1653.
8. Consensus Development Statement (1997) European Foundation for Osteoporosis and the National Osteoporosis Foundation. Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 7, 1-6.
9. Cook JGH (1975) Factors influencing the assay of creatinine. Ann Clin Biochem 12, 219-232.
10. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM & Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137, 1001-1005.
11. Coxam V, Bowman BM, Mecham M, Roth CM, Miller MA & Miller SC (1996) Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth and formation rates in ovariectomized rats. Bone 19, 107-114.
12. Cuzzocrea S, Santagati S, Sautebin L, Mazzon E, Calabro I, Caputi AP & Maggi A (2000) 17 beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology 141, 1455-1463.
13. Das UN (1991) Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rhumatoid arthritis and other collagen vascular diseases. Prostaglandins Leucot Essent Fatty Acids 44, 201-210.
14. Das UN (2002) Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp Biol Med 227, 88-93.
15. De la Puerta R, Ruiz Gutierrez V & Hoult JR (1999) Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol 57, 445-449.
16. Diplock AT, Aggett P, Ashwell M, Bornet F, Fern EB & Roberfroid MB (1999) Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 81, S1-S27.
17. Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RG & Riggs BL (1992) Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 74, 487-494.
18. Ershler WB, Harman SM & Keller ET (1997) Immunologic aspects of osteoporosis. Dev Comp Immunol 21, 487-499.
19. European Commission (1998) Report on Osteoporosis in the European Community: Action for Prevention. Luxembourg: Office for Official Publication of the European Communities.
20. Fournier T, Medjoubi N & Porquet D (2000) Alpha-1-acid glycoprotein. Biochim Biophys Acta 1482, 157-171.
21. Horcajada-Molteni MN & Coxam V (2001) Flavonols and idoflavones prevent bone loss in the ovariectomized rat, a model for postmenopausal osteoporosis. In Nutritional Aspects of Osteoporosis, pp. 325-340 [F Burkhardt, B Dawson-Hughes and RP Heaney, editors]. San Diego, CA: Academic Press.
22. Horowitz MC & Raisz LG (1999) Cytokines and Prostaglandins. In Aging Skeleton, pp. 195-207 [CJ Rosen, J Glowack and JP Bilezikian, editors]. San Diego: Academic Press.
23. Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15, 175-191.
24. Kanis JA (1993) The incidence of hip fracture in Europe. Osteoporos Int 3, 10-15.
25. Keys A, Menotti A, Karvenen MJ, Arvanis C, Blackbuen H, Buzina R, Djordjevic BS, Donsas AS, Fidanza F & Keys MH (1986) The diet and 15-years death rate in the seven countries study. Am J Epidemiol 24, 903-915.
26. Martinez-Dominguez E, De La Puerta R & Ruiz-Guitiérrez V (2001) Protective effects upon experimental inflammation models of polyphenol-supplemented virgin olive oil diet. Inflamm Res 50, 102-106.
27. Martin-Moreno JM, Willett WC, Gorgojo L, Banegas JR, Rodriguez-Artalejo F, Fernandez-Rodriguez JC, Maisonneuve P & Boyle P (1994) Dietary fat, olive oil intake and breast cancer risk. Int J Cancer 58, 774-780.
28. Miller SC, Bowmann BM, Miller MA & Bagi C (1991) Calcium absorption and osseous organ, tissue and envelope specific changes following ovariectomy in rats. Bone 12, 439-446.
29. Minne HW, Pfeilschifter J, Scharla S, Mutschelknauss S, Schwarz A, Krempien B & Ziegler R (1984) Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology 115, 50-54.
30. Mody N, Parhami F, Sarafian TA & Demer L (2001) Oxidative stress modulates osteoblastic differenciation of vascular and bone cells. Free Radic Biol Med 31, 509-519.
31. Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
32. Pacifi R, Brown C, Puscheck E, Slatopolsky E, Maggio D, McCracken R & Avioli LV (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88, 5134-5138.
33. Quaranta G & Rotundo V (2000) Economic and commercial prospects for olive oil in view of the changes in the common market organisation (CMO) (part one). Olivae 91, 20-24.
34. Riggs BL & Melton LJ (1986) Involutional osteoporosis. N Engl J Med 26, 1676-1684.
35. Robbins SP (1994) Biochemical markers for assessing skeletal growth. Eur J Clin Nutr 48, S199-S209.
36. Tsarbopoulos A, Gikas E, Papadopoulos N, Aligiannis N & Kafatos A (2003) Simultaneous determination of oleuropein and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr B 785, 157-164.
37. Tuck KL, Freeman MP, Hayball PJ, Stretch GL & Stupans I (2001) The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J Nutr 131, 1993-1996.
38. Turner CH & Burr CB (1993) Basic mechanical measurements of bone: a tutorial. Bone 14, 595-608.
39. Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C & Delmas PD (1991) Effects of menopause and hormone therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 72, 367-373.
40. Visioli F, Bellomo G & Galli C (1998) Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 247, 60-64.
41. Vissers MN, Zock PL, Roodenburg AJ, Leenen R & Katan MB (2002) Olive oil phenols are absorbed in humans. J Nutr 132, 409-417.
42. Vukicevic S, Marusic A, Stavljenic A, Cesnjaj M & Ivankovic D (1994) The role of tumor necrosis factors-alpha in the generation of acute phase response and bone loss in rats with talc gramulomastosis. Lab Invest 70, 386-391.
43. Watkins BA, Lippman HE, Bouteiller LL, Li Y & Seifert MF (2001) Bioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res 40, 125-148.
44. Zeng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, Franchimont N, Geenen V, Albert A & Reginster JY (1997) Increase in cytokine production (II-1 beta, II-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 26, 63-71.